Search Results - Xinyan Li

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Bibliometrics and visual analysis of the research status and trends of placenta accreta spectrum disorder over the past decade

    Bibliometrics and visual analysis of the research status and trends of placenta accreta spectrum disorder over the past decade by Xinyan Li, Qiuying Li, Huiyun Hu, Xiaomei Li

    Published 2025-12-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Update of safety profile of bile acid sequestrants: A real-world pharmacovigilance study of the FDA adverse event reporting system

    Update of safety profile of bile acid sequestrants: A real-world pharmacovigilance study of the FDA adverse event reporting system by Wangqi Chen, Yuxia Xie, Qinghua Li, Zhenghui Zhu, Xinyan Li, Hong Zhu

    Published 2025-01-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Update of safety profile of bile acid sequestrants: A real-world pharmacovigilance study of the FDA adverse event reporting system.

    Update of safety profile of bile acid sequestrants: A real-world pharmacovigilance study of the FDA adverse event reporting system. by Wangqi Chen, Yuxia Xie, Qinghua Li, Zhenghui Zhu, Xinyan Li, Hong Zhu

    Published 2025-01-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Gypensapogenin I alleviates PANoptosis, ferroptosis, and oxidative stress in myocardial ischemic–reperfusion injury by targeting the NOX2/AMPK pathway

    Gypensapogenin I alleviates PANoptosis, ferroptosis, and oxidative stress in myocardial ischemic–reperfusion injury by targeting the NOX2/AMPK pathway by Yuqiong Chen, Bo Guan, Jian Lu, Xiaopei Yan, Chao Huang, Yuli Qiu, Xinyan Li, Xiangyu Sun, Lin Chen, Wei Li, Wenjun Mao, Zhongqi Sun, Bin Xu, Su Li, Chao Chen, Chao Chen

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Hepatoprotective drug screening identifies daclatasvir, a promising therapeutic candidate for MASLD by targeting PLIN2

    Hepatoprotective drug screening identifies daclatasvir, a promising therapeutic candidate for MASLD by targeting PLIN2 by Rui Shu, Song Tian, Weiyi Qu, Jinjie Yang, Wei Shi, Xinyan Li, Toujun Zou, Changjin Jiang, Yuxuan Zhang, Zifeng Yang, Han Tian, Hailong Yang, Jiajun Fu, Zhi-Gang She, Hongliang Li, Xiao-Jing Zhang

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: